2007/47/EC: why buying standards revisions can be frustrating
This article was originally published in Clinica
Executive Summary
Manufacturers and consultants in the UK, and very likely elsewhere in the EU, who need to keep abreast with the latest standards changes may be questioning the costs of standards revised in the light of Directive 2007/47/EC which amends the medical device directives, given how minor some of the changes may be.
You may also be interested in...
EU Regulatory Roundup, March 2024: Busy Agenda In Broad Range Of Key Areas
March was an important month for EU medtech regulation with an interesting spread of news relating to the Medical Device and IVD Regulations, the Batteries Regulation, the Artificial Intelligence Act and more.
EU’s Revised Phthalates Guideline Features New Annexes Focused On Alternatives
The effects of phthalates, plasticizers used in many medical devices, on the human endocrine system, have long been debated. But how safe are the alternatives? Updated guidelines give more insight.
Non-Medical Brain Stimulation Devices: Could They Be Down-Classified Again In the EU?
Six types of products that do not have an intended medical purpose fall under the scope of the Medical Device Regulation. Understanding their risks is complex and subject to regular re-examination by the European Commission.